article thumbnail

Pharma, patient advocates clash over Inflation Reduction Act

Pharmaceutical Technology

Merith Basey, the executive director of the advocacy group Patients for Affordable Drugs, said that CMS’s lack of negotiating power is a key reason that US patients pay up to four times as much for drugs as patients in other countries.

article thumbnail

Pharma’s ESG goals need to underscore push for health equity

Pharmaceutical Technology

Over recent years, many pharmaceutical companies have taken up environment, social and governance (ESG) targets in order to prioritize sustainability whilst boosting their external public relations. GlobalData is the parent company of Pharmaceutical Technology. Reaching social and governance goals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why Decentralized Clinical Trials Are the Wave of the Future

Salesforce

The past 16 months have forced pharmaceutical companies to adapt their clinical trials to new ways of living and working. Social distancing protocols spurred by the pandemic led to 76% of more than 200 clinical trial sponsors conducting most or all of their patient monitoring remotely. Will patients take part?

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

From new legislation to functional shifts in marketing and advertising, the pharma industry works hard every day to keep up with new regulatory requirements and the constantly evolving expectations of prescribers and patients. – Increased Caution From Patients & Prescribers. – New & Updated Legislation.

Pharma 52
article thumbnail

2022 in review: Regulation starts to catch up with AI in pharma

Pharmaceutical Technology

This action was part of the UK’s National AI Strategy of which the third pillar is “Governing AI effectively”. In pharmaceutical research, this may help secure the privacy of patient data used by AI systems and decrease bias due to ethnicity, sex and other factors. China takes an aim at recommendation algorithms.

Pharma 140
article thumbnail

Beating the Big C

Pharmaceutical Technology

It has boosted anti-tumour research by 60% since 2005, at a cost of $1.6bn, in the hope of increasing the share of company sales attributed to cancer drugs from the current level of 5% “There are a lot of patients that are suffering,” said Pfizer chief executive Jeffrey Kindler.

article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. This is to ensure patient safety, as outlined in The Medicines for Human Use (Clinical Trials) Regulations 2004. However, the ABPI is more cautious.

Pharma 98